Bank Of Nova Scotia Regeneron Pharmaceuticals, Inc. Transaction History

Bank Of Nova Scotia

  • $47.4 Billion
  • Q3 2024

A detailed history of Bank Of Nova Scotia transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 98,691 shares of REGN stock, worth $73 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
98,691
Previous 96,136 2.66%
Holding current value
$73 Million
Previous $101 Million 2.68%
% of portfolio
0.22%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1024.09 - $1201.76 $2.62 Million - $3.07 Million
2,555 Added 2.66%
98,691 $104 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $62.6 Million - $76 Million
70,928 Added 281.37%
96,136 $101 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $1.75 Million - $1.93 Million
-1,940 Reduced 7.15%
25,208 $24.3 Million
Q4 2023

Feb 12, 2024
SELL
$775.18 - $881.7 $18.9 Million - $21.4 Million
-24,320 Reduced 47.25%
27,148 $23.8 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $17.8 Million - $21.7 Million
25,722 Added 99.91%
51,468 $42.4 Million
Q2 2023

Aug 03, 2023
BUY
$700.03 - $830.35 $12.6 Million - $15 Million
18,055 Added 234.75%
25,746 $18.5 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $4.87 Million - $5.92 Million
-7,158 Reduced 48.21%
7,691 $6.32 Million
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $9.17 Million - $9.96 Million
-12,993 Reduced 46.67%
14,849 $10.7 Million
Q3 2022

Nov 10, 2022
SELL
$573.97 - $724.32 $7.42 Million - $9.36 Million
-12,922 Reduced 31.7%
27,842 $19.2 Million
Q2 2022

Aug 08, 2022
BUY
$548.35 - $738.84 $21 Million - $28.2 Million
38,217 Added 1500.47%
40,764 $24.1 Million
Q2 2022

Aug 05, 2022
SELL
$548.35 - $738.84 $6.7 Million - $9.03 Million
-12,223 Reduced 82.76%
2,547 $1.51 Million
Q1 2022

May 09, 2022
SELL
$595.12 - $698.43 $23.4 Million - $27.5 Million
-39,335 Reduced 72.7%
14,770 $10.3 Million
Q4 2021

Feb 11, 2022
SELL
$543.48 - $670.97 $37.5 Million - $46.3 Million
-69,070 Reduced 56.07%
54,105 $34.2 Million
Q3 2021

Nov 12, 2021
SELL
$574.03 - $680.96 $12.9 Million - $15.3 Million
-22,473 Reduced 15.43%
123,175 $74.5 Million
Q2 2021

Aug 12, 2021
BUY
$472.8 - $558.54 $68.9 Million - $81.4 Million
145,648 New
145,648 $81.4 Million

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bank Of Nova Scotia Portfolio

Follow Bank Of Nova Scotia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email